Health Care & Life Sciences » Biotechnology | Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $0.17
Market Cap
 $137.75 M
Shares Outstanding
 544.47 M
Public Float
 504.11 M

Profile

Address
4800 Montgomery Lane
Bethesda Maryland 20814
United States
Employees -
Website http://www.nwbio.com
Updated 07/08/2019
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines.

Financials

View All
Created with Highcharts 5.0.14Northwest Biotherapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.65 78965 789135 634135 634114 741114 74185 86185 86173 14373 14335 79435 794201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Northwest Biotherapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.8098091 4541 4541 7391 7396236233363364124122013201420152016201720180500100015002000

Linda F. Powers
Chairman, President & Chief Executive Officer
Alton L. Boynton
Secretary, Director & Chief Scientific Officer
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.